Funder: National Institutes of Health

Due Dates: September 5, 2024 | January 5, 2025 | April 5, 2025 | September 5, 2025 | January 5, 2026 | April 5, 2026 | September 5, 2026 | January 5, 2027 | April 5, 2027

Funding Amounts: Up to $3,000,000 total for Phase IIB (max $1,500,000/year, up to 3 years); third-party matching funds required.

Summary: Supports U.S. small businesses seeking to advance NINDS-related clinical trials or research for products previously funded by NIH SBIR/STTR Phase II awards, with a focus on commercialization.

Key Information: Applicants must secure independent third-party investor funding equal to or greater than the NINDS funds requested; only U.S. small businesses are eligible.